Can-Fite BioPharma American Depositary Shares
CANF
10 hedge funds and large institutions have $1.87M invested in Can-Fite BioPharma American Depositary Shares in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
38% more capital invested
Capital invested by funds: $1.35M → $1.87M (+$518K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
9% less funds holding
Funds holding: 11 → 10 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$461K |
| 2 |
Morgan Stanley
New York
|
+$56.2K |
| 3 |
VF
Virtu Financial
New York
|
+$33.7K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$15K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$130K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$37.5K |
| 3 |
Jane Street
New York
|
-$12K |
| 4 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.75K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TAM
1
Taylor Asset Management
Toronto,
Ontario, Canada
| $1.03M | – | – | – |
|
|
MIH
2
Meitav Investment House
Bene-Beraq,
Israel
| $488K | +$461K | +123 | New |
|
|
3
Morgan Stanley
New York
| $247K | +$56.2K | +15 | +31% |
|
|
VF
4
Virtu Financial
New York
| $35K | +$33.7K | +9 | New |
|
|
RJA
5
Raymond James & Associates
St Petersburg,
Florida
| $18K | – | – | – |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $17K | -$37.5K | -10 | -71% |
|
|
TSS
7
Two Sigma Securities
New York
| $17K | +$15K | +4 | New |
|
|
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $10.3K | – | – | – |
|
|
AF
9
Advisornet Financial
Minnetonka,
Minnesota
| $4K | – | – | – |
|
|
IA
10
IFP Advisors
Tampa,
Florida
| $3K | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| $2K | -$3.75K | -1 | Closed |
|
|
SM
12
Sabby Management
Miami Beach,
Florida
| – | -$130K | -37 | Closed |
|
|
13
Jane Street
New York
| – | -$12K | -3 | Closed |
|
|
TDC
14
Thompson Davis & Co
Richmond,
Virginia
| – | -$9K | -3 | Closed |
|
|
CF
15
Centaurus Financial
Anaheim,
California
| – | -$2K | – | – |
|
CANF Hedge Fund Activity: Q3 2018 in Review
10 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q3 2018, worth a combined $1.87M — up 38% from $1.35M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CANF and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Meitav Investment House, opening a new position worth an estimated $461K. The largest seller was Sabby Management, exiting entirely with an estimated $130K sold.
- 10 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q3 2018, down from 11 in Q2 2018.
- Funds reported $1.87M of Can-Fite BioPharma American Depositary Shares stock for Q3 2018, up 38% quarter-over-quarter.
- 3 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q3 2018 and 4 closed out, a net change of -1 holder.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q3 2018 was Meitav Investment House, an estimated $461K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q3 2018 was Sabby Management, an estimated $130K sold.
Based on aggregated 13F filings for Q3 2018.